Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. - Wikidata - awgldk - TriplyDB

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

http://www.wikidata.org/entity/Q41029212

about

Future therapy of portal hypertension in liver cirrhosis - a guess.Pathobiology of liver fibrosis: a translational success story Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model Effects of Fibrotic Tissue on Liver-targeted Hydrodynamic Gene Delivery Adipocytokines and hepatic fibrosis.Novel treatment options for portal hypertension.Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.Rationale for the use of statins in liver disease.Renin angiotensin system in liver diseases: Friend or foe?Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.The Cooperative Effect of Local Angiotensin-II in Liver with Adriamycin Hepatotoxicity on Mitochondria.Hepatic stellate cells as key target in liver fibrosis.The carbon tetrachloride model in mice.DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis.Hepatic stellate cell activation and pro-fibrogenic signals.Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms.Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension.Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.Managing portal hypertension in patients with liver cirrhosis.Research progress on signaling pathways in cirrhotic portal hypertension

P2860

Q34446521-736B5708-E5B1-4B37-A155-60EC1E0890CD Q34462733-036E01CF-856E-41CC-B932-25D11BBC8657 Q35622533-9613D618-3483-4609-BF86-D42005CA7FA7 Q35787734-AEE8B5CC-622C-453D-B242-AEDF36D3BFA9 Q36121721-8520A2A8-5D13-4C4F-9088-D38679EA7C8A Q36339714-D173ED34-9B6D-4861-9BB4-42ADB5F695D4 Q37234552-21AEE2A2-30B3-4CE7-9600-43B7D15F62DE Q37256214-DA423BCD-CAE9-42CD-855B-2789C9640092 Q38346026-41202FF0-66A0-414B-81C3-D79AA4F53B5C Q38680437-2783498E-7803-4264-BBD0-98FA24DDD6E1 Q38820953-E01B4723-B0C9-42C0-90AE-69456D0A1F7D Q38831994-C56396DF-2159-47FC-B6EA-5E9850A3E5BA Q39171942-B8AFA23D-1C56-46BC-B2F0-C78354A01D9E Q39360840-0FB5F1B5-DB0F-44E2-97B4-29499136678F Q39429850-F16EF570-AC19-48E1-8581-B1709DB136C6 Q39647330-047E0A2E-6944-4883-B9EA-B2E010028FFC Q39740192-3A45FF40-56E5-4C6A-A85E-279647BC4979 Q40200602-2C9DB760-CD67-4BA5-A041-1C3F9FE1C231 Q41121854-A1B80F25-21D2-4A16-9523-8011C7A14D26 Q41372298-07CA204C-354E-44D9-9083-D7C643DE118F Q42371476-FA8C06B6-44D9-4313-AF29-77C3D9344571 Q46347192-45662112-FB61-49F0-9EF2-09D1872F3598 Q47230773-866B317D-4410-4D68-92DB-828600A1DC57 Q53817185-07648B72-0174-4BBE-B90D-302BD1801AEC Q53834535-0B6171BB-070A-43A0-92D1-887AE5B2E79F Q54978608-94DDC8B2-DCA0-4D77-B4C6-CDBF205006CD Q55038505-2434BE47-FDE5-487D-87D9-E2CCFE362E8E Q55278061-9E2F106A-9EA8-4FDD-B8B9-A04492F1C736 Q57069571-379DB4BA-3C91-4AD7-BE9F-2A64A67D367B

P2860

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

http://www.wikidata.org/entity/Q41029212

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

@en

type

label

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

@en

prefLabel

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

@en

P1433

Q41029212-6878CF42-3026-4229-9A28-FF7BDF3ED609

P1476

Q41029212-50A28727-47C4-4E69-BE08-730450C78FE1

P2093

Q41029212-074502E9-4916-47A7-9101-80371BE95578

Q41029212-0F591C3A-B691-4F83-B2CC-0F8EF60E031A

Q41029212-44269AFA-7344-45D8-B1F4-2479E241F951

Q41029212-46FD312E-5F28-4CBC-A89B-BE387B4CCD18

Q41029212-6699968B-34CE-4815-BCE6-53E8A04506F1

Q41029212-728F4BAD-1F6B-44C6-9832-BE75D5E34554

Q41029212-8D59161B-72F9-4041-98BE-AB0F318C64C2

Q41029212-9A684F39-3F57-40BD-80AF-183A9DF5DD64

Q41029212-9A6DBF1E-996F-489D-8351-B08E05F0BA19

Q41029212-CB009D79-0BD2-4A41-8765-CAA35DE86318

P2860

Q41029212-01CD914B-E7BE-4CE0-89C6-3D09101A3E00

Q41029212-0431F1EA-80AD-4921-938B-26571EDE5839

Q41029212-052E5C9E-DE3D-429F-9FF8-37EB45F8E3FD

Q41029212-06F1B435-FD38-4A5F-A226-A5C6587E5AE0

Q41029212-0E8D70E9-115C-4332-A46D-3C1F36F06FB8

Q41029212-0F7DF8D8-B36F-4E29-899E-46F8EAB47C50

Q41029212-16162562-7B23-45BB-886E-EEAF6F96C749

Q41029212-1AF970BF-D34F-4243-8573-235C787EE316

Q41029212-1FE9F594-45B0-45D6-94E2-FED541B4BA6E

Q41029212-26F35935-98FE-4CE4-811F-339A73EF6EBD

P304

Q41029212-53166999-C6E7-49CA-BE65-DF32A293C6CB

P31

Q41029212-4E261A4D-1430-4B02-B36F-BA20C559EC7C

P356

Q41029212-DC9AD1B3-8D60-4A7B-AD76-ED3F10C97D3A

P407

Q41029212-F852CECE-42EF-497F-84F1-62F761425B45

P433

Q41029212-3948C77E-C112-4679-821C-A3B83D6DE774

P478

Q41029212-5C883391-F496-4351-B9B0-E45EBD5E3641

P50

Q41029212-0462499F-EA34-4DC4-A9B8-D04F3903DFFE

Q41029212-3F5BC22F-847D-4ADF-91DF-F8CA99D1A1F1

Q41029212-818EFDF3-2070-45A9-942D-38A6BA12A97C

Q41029212-F1DCC56E-FB74-489A-B9EF-68B4DCA8E8DC

Q41029212-FFF4699D-2544-4C05-99BD-E2B81B601E3F

P577

Q41029212-C05828A2-60CE-4BC0-A243-BE14AF5210F5

P5875

Q41029212-7EB24032-C157-4709-9D00-0B184E15A026

P698

Q41029212-4FF56E93-E3C2-48CC-8171-8434E168CC3B

P932

Q41029212-E5A36510-CC9F-419C-94FB-2EA91DF4E8EC

P356

P1433

P1476

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

@en

P2093

Alexandra Wojtalla

http://www.w3.org/2001/XMLSchema#string

Annabelle Vogt

http://www.w3.org/2001/XMLSchema#string

Benita Kowallick

http://www.w3.org/2001/XMLSchema#string

Benjamin Krämer

http://www.w3.org/2001/XMLSchema#string

Dieter O Fürst

http://www.w3.org/2001/XMLSchema#string

Frank A Schildberg

http://www.w3.org/2001/XMLSchema#string

Irela G Reza Mazar

http://www.w3.org/2001/XMLSchema#string

Jacob Nattermann

http://www.w3.org/2001/XMLSchema#string

Maria A Gonzalez-Carmona

http://www.w3.org/2001/XMLSchema#string

Markus Linhart

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin signalling in pulmonary fibrosis

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

The world health report 2002 - reducing risks, promoting healthy life

Mechanisms of hepatic fibrogenesis

Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Complications of cirrhosis. I. Portal hypertension.

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

P304

334-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27117

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Percy A. Knolle

Robert Schierwagen

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260718564

http://www.w3.org/2001/XMLSchema#string

P698

24619965

http://www.w3.org/2001/XMLSchema#string

P932

5512562

http://www.w3.org/2001/XMLSchema#string